CHEMOMETEC A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 312.8 DKK | -0.64% |
|
+6.11% | -19.38% |
| Apr. 12 | Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024 | CI |
| Apr. 12 | ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 404M 58.04M | Sales 2025 * | 471M 67.7M | Capitalization | 5.44B 783M |
|---|---|---|---|---|---|
| Net income 2024 * | 134M 19.28M | Net income 2025 * | 157M 22.58M | EV / Sales 2024 * | 12.6 x |
| Net cash position 2024 * | 343M 49.33M | Net cash position 2025 * | 403M 58.04M | EV / Sales 2025 * | 10.7 x |
| P/E ratio 2024 * |
40.7
x | P/E ratio 2025 * |
34.7
x | Employees | 171 |
| Yield 2024 * |
2.08% | Yield 2025 * |
2.56% | Free-Float | 100% |
More Fundamentals
* Assessed data
More news
Latest transcript on ChemoMetec A/S
More press releases
More news
| 1 day | -0.64% | ||
| 1 week | +6.11% | ||
| Current month | +4.62% | ||
| 1 month | -16.99% | ||
| 3 months | -34.97% | ||
| 6 months | -10.68% | ||
| Current year | -19.38% |
1 week
290.00
317.60
1 month
281.20389.00
Current year
281.20554.00
1 year
255.00554.00
3 years
255.001 149.00
5 years
134.001 149.00
10 years
3.261 149.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 65 | 96-12-31 | |
| Director of Finance/CFO | - | 22-10-31 | |
Søren Kjærulff
CTO | Chief Tech/Sci/R&D Officer | - | 07-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Peter Reich
BRD | Director/Board Member | 62 | 14-09-30 |
| Founder | 65 | 96-12-31 | |
Kristine Færch
BRD | Director/Board Member | 48 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 0 M€ | -.--% | - | |
| 0.01% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 312.8 | -0.64% | 83,650 |
| 24-05-07 | 314.8 | +4.86% | 70,583 |
| 24-05-06 | 300.2 | +1.15% | 50,953 |
| 24-05-03 | 296.8 | +2.34% | 79,708 |
| 24-05-02 | 290 | -1.63% | 54,892 |
Delayed Quote Nasdaq Copenhagen, May 08, 2024 at 10:59 am EDT
More quotes
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Companyâs activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Companyâs analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.
Calendar
2024-09-10
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
312.8
DKK
Average target price
462.5
DKK
Spread / Average Target
+47.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.38% | 784M | |
| +73.50% | 12.41B | |
| -19.26% | 7.87B | |
| +2.40% | 6.37B | |
| +3.66% | 5.81B | |
| +11.89% | 5.36B | |
| +37.45% | 4.92B | |
| -19.73% | 4.02B | |
| -35.58% | 2.43B | |
| +0.74% | 2.02B |
- Stock Market
- Equities
- CHEMM Stock